AUPH News and Press, Aurinia Pharmaceuticals Inc From 07/15/22

Aurinia Pharmaceuticals ( NASDAQ: AUPH ) plunged 14% after the company announced Thursday three new executive hires, including a new R&D chief, likely cooling speculation that the company may be acquired. Aurinia also disclosed that its chief commercial officer will be...

Gainers: NexImmune ( NEXI ) +34% . Allogene Therapeutics ALLO +12% . SOPHiA GENETICS ( SOPH ) +12% . Verona Pharma ( VRNA ) +8% . R1 RCM ( RCM ) +7% . Losers: Codexis ( CDXS ) -43% . 10x Genomics ( TXG ...

Codexis ( CDXS ) -23% as forecast comes below estimates . 10x Genomics ( TXG ) -19% on guiding Q2 revenues below consensus . Innovative Industrial Properties ( IIPR ) -21% . Lantern Pharma ( LTRN ) -10% . Sunrun ( RUN ) -8%...

Gainers: Avadel Pharmaceuticals ( AVDL ) +5% . Cerence ( CRNC ) +4% . Tricida ( TCDA ) +3% . Plains All American Pipeline ( PAA ) +3% . Vir Biotechnology ( VIR ) +2% . Losers: Codexis ( CDXS ) -18% . 10x Genom...

Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipeline Scott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities...

The most recent two hottest potatoes in the biotech arena are Aurinia Pharmaceuticals and Seagen. While the latter is mostly/recently associated with an upcoming Merck buyout, the former has been associated with many big pharma names. It's clear (to us) that AUPH should be on the ...

Shares of the commercial-stage biopharma Aurinia Pharmaceuticals (NASDAQ: AUPH) rose by as much as 13.7% during Friday's trading session. The drugmaker's stock perked up today in response to yet another buyout rumor. This time around, Japanese drug manufacturer Otsuka Hold...

Aurinia Pharmaceuticals ( NASDAQ: AUPH ) rose 8% on speculation the company may be a target for Otsuka ( OTCPK:OTSKF ). Aurinia ( AUPH ) could be a potential takeover target for Otuska, according to a Betaville item earlier. Recall late May, Aurinia Pharmac...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced that the Company’s Compensation Committee granted 11 new employees inducement stock ...

At 2022 Russell indexes annual reconstitution, following notable health care stocks will be added to and deleted from the Russell 3000 Index. Notable additions: Clover Health Investments (CLOV), Aurinia Pharmaceuticals (AUPH), Nano-X Imaging (NNOX), ADMA Biologics (ADMA),&...